EN

GLP‑1 medicines and prices in Canada

Every GLP‑1 medicine sold in Canada, at every dose: the price of a pack, and what that comes to a month and a year.

Prices here are official figures in Canadian dollars: Ontario's public drug formulary,1 the maker's price submitted to Canada's Drug Agency,2 or the BC Ministry of Health's wholesale estimate, marked ≈ (without pharmacy markup or fee).3 What you pay depends on your provincial plan or private insurance.

Before you go further. These are prescription drugs. A prescriber decides with you whether one fits, and which.4 They have real risks: read Side effects and risks first. A lower price doesn't make a medicine right for you.

How much do Wegovy, Ozempic and Zepbound cost in Canada?

Every GLP‑1 medicine sold in Canada, by dose. Prices checked 12 Oct 2026.
Dose and packPer packPer monthPer year
DulaglutideAbout dulaglutide →
TrulicityType 2 diabetes onlyEli Lilly · Weekly injection, single-dose pens (4 a pack)Approved for: Type 2 diabetes (adults)5
0.75 mg4 pens (4 weekly doses)≈ $264.663≈ $287≈ $3,441
1.5 mg4 pens (4 weekly doses)≈ $266.583≈ $289≈ $3,466

Approximate wholesale cost from the BC Ministry of Health's diabetes drug table (September 2026; McKesson prices of 27 July 2026, without pharmacy markup or fee): about $3,450 a year at 0.75 mg and $3,475 at 1.5 mg, which we divide by 365 days. Not on Ontario's formulary. The 3 mg and 4.5 mg pens are approved but not sold in Canada.3
LiraglutideAbout liraglutide →
SaxendaNovo Nordisk · Daily injection, pen (18 mg)Approved for: Weight management (adults and teens 12+)6
0.6 mg1 18 mg pen, lasts 30 days at this dose≈ $90.417≈ $91≈ $1,097
1.2 mg1 18 mg pen, lasts 15 days at this dose≈ $90.417≈ $183≈ $2,194
1.8 mg1 18 mg pen, lasts 10 days at this dose≈ $90.417≈ $274≈ $3,291
2.4 mg1 18 mg pen, lasts 7.5 days at this dose≈ $90.417≈ $366≈ $4,388
3 mg1 18 mg pen, lasts 6 days at this dose≈ $90.417≈ $457≈ $5,485

Approximate wholesale cost from the BC Ministry of Health's weight-loss drug table (May 2024; McKesson prices of 27 May 2024, without pharmacy markup or fee): about $5,500 a year at 3 mg a day, which is about $90.41 for an 18 mg pen. The newest official figure we found, so today's price may differ.7
VictozaType 2 diabetes onlyNovo Nordisk · Daily injection, pen (18 mg)Approved for: Type 2 diabetes (adults)8
0.6 mg1 18 mg pen, lasts 30 days at this dose≈ $117.263≈ $119≈ $1,423
1.2 mg1 18 mg pen, lasts 15 days at this dose≈ $117.263≈ $237≈ $2,846
1.8 mg1 18 mg pen, lasts 10 days at this dose≈ $117.263≈ $356≈ $4,268

Approximate wholesale cost from the BC Ministry of Health's diabetes drug table (September 2026; McKesson prices of 27 July 2026, without pharmacy markup or fee): about $4,280 a year at 1.8 mg a day, which is about $117.26 for an 18 mg pen. Not on Ontario's formulary.3
SemaglutideAbout semaglutide →
Generic semaglutideType 2 diabetes onlyApotex; Dr. Reddy's · Weekly injection, pen (4 doses)Approved for: Type 2 diabetes (adults)9
0.25 mg1 pen, lasts 8 weeks at this dose$78.141$42$508
0.5 mg1 pen (4 weekly doses)$78.141$85$1,016
1 mg1 pen (4 weekly doses)$78.141$85$1,016

Ontario Drug Benefit formulary price per pen, checked 12 Oct 2026. Interchangeable with Ozempic. The 0.25/0.5 mg pen holds 4 doses of 0.25 mg and 2 of 0.5 mg, so a 0.25 mg week costs an eighth of a pen. Pens were in short supply in July 2026, and some lots were recalled in August 2026.1
OzempicType 2 diabetes onlyNovo Nordisk · Weekly injection, pen (4 doses)Approved for: Type 2 diabetes (adults)10
0.25 mg1 pen, lasts 8 weeks at this dose$227.941$123$1,482
0.5 mg1 pen (4 weekly doses)$227.941$247$2,963
1 mg1 pen (4 weekly doses)$227.941$247$2,963
2 mg1 pen (4 weekly doses)Not published No price for the 2 mg pen in the Ontario formulary we checked.

Ontario Drug Benefit formulary price per pen, checked 12 Oct 2026. The Ontario plan itself pays the lower generic price. The 0.25/0.5 mg pen holds 4 doses of 0.25 mg and 2 of 0.5 mg, so a 0.25 mg week costs an eighth of a pen. We found no price for the 2 mg pen in the formulary we checked.1
RybelsusType 2 diabetes onlyNovo Nordisk · Daily tablet, packs of 30Approved for: Type 2 diabetes (adults)11
3 mg30 tablets (30 days)$225.911$228$2,741
7 mg30 tablets (30 days)$225.911$228$2,741
14 mg30 tablets (30 days)$225.911$228$2,741

Ontario Drug Benefit formulary price, $7.5303 a tablet at every strength (so $225.91 for 30 tablets), checked 12 Oct 2026. Limited Use for type 2 diabetes. The newer 1.5, 4 and 9 mg tablets replace 3, 7 and 14 mg dose for dose, at the same price.1
SevmiaApotex · Weekly injection, 1 mg pen (4 doses)Approved for: Weight management (adults and teens 12+); Heart-risk reduction12
1 mg1 pen (4 weekly doses)$325.051$352$4,226

Ontario Drug Benefit formulary price per pen, $325.048, checked 12 Oct 2026. Listed as off-formulary interchangeable, so Ontario's public plan doesn't pay for it. The pen only gives 1 mg doses.1
WegovyNovo Nordisk · Weekly injection, FlexTouch pen (4 doses)Approved for: Weight management (adults and teens 12+); Heart-risk reduction; MASH liver disease13
0.25 mg1 pen (4 weekly doses)$388.642$421$5,052
0.5 mg1 pen (4 weekly doses)$388.642$421$5,052
1 mg1 pen (4 weekly doses)$388.642$421$5,052
1.7 mg1 pen (4 weekly doses)$388.642$421$5,052
2.4 mg1 pen (4 weekly doses)$388.642$421$5,052

The maker's price submitted to Canada's Drug Agency, the same at every strength.2
TirzepatideAbout tirzepatide →
MounjaroType 2 diabetes onlyEli Lilly · Weekly injection, KwikPen (4 doses)Approved for: Type 2 diabetes14
2.5 mg1 pen (4 weekly doses)$30015$325$3,900
5 mg1 pen (4 weekly doses)$30015$325$3,900
7.5 mg1 pen (4 weekly doses)$42015$455$5,460
10 mg1 pen (4 weekly doses)$42015$455$5,460
12.5 mg1 pen (4 weekly doses)$54015$585$7,020
15 mg1 pen (4 weekly doses)$54015$585$7,020

The maker's price submitted to Canada's Drug Agency, per pen of 4 weekly doses: $300 at 2.5 and 5 mg, $420 at 7.5 and 10 mg, $540 at 12.5 and 15 mg. Not a formulary price: no public plan lists tirzepatide.15
ZepboundEli Lilly · Weekly injection, KwikPen (4 doses)Approved for: Weight management (adults); Sleep apnea with obesity16
2.5 mg1 pen (4 weekly doses)$30017$325$3,900
5 mg1 pen (4 weekly doses)$30017$325$3,900
7.5 mg1 pen (4 weekly doses)$42017$455$5,460
10 mg1 pen (4 weekly doses)$42017$455$5,460
12.5 mg1 pen (4 weekly doses)$54017$585$7,020
15 mg1 pen (4 weekly doses)$54017$585$7,020

The maker's price submitted to Canada's Drug Agency, per pen of 4 weekly doses: $300 at 2.5 and 5 mg, $420 at 7.5 and 10 mg, $540 at 12.5 and 15 mg. Not a formulary price: no public plan lists tirzepatide.17

Per month and per year. A year is 52 weeks: 52 weekly doses, or 364 days of a daily medicine. We work out the cost of one dose (or one day) from the pack, multiply it by 52 (or 364) for the year, and divide the year by 12 for a month. So a month of a weekly pen costs a little more than one pen of 4 doses: a year takes 13 pens, not 12. This is the method our cost calculator uses. Rounded to the nearest dollar.

Grouped by medicine, in alphabetical order. Not sorted by price, and not a recommendation. We don't list or link pharmacies, clinics or online sellers. Your prescriber sets the medicine and the dose.

How we get these prices

Official prices only, in Canadian dollars: Ontario's public formulary, the maker's price submitted to Canada's Drug Agency, or the BC Ministry of Health's wholesale estimate. Never a savings-card, pharmacy, clinic or promotional price. A dose with no official price is null and shown as 'Not published'.

Prices checked
12 Oct 2026
Next check
November 2026

How we write and check prices · Cost calculator

More on prices and paying

Cost calculatorAdd up a plan over months, with the dose steps. CoverageHow people pay in Canada. CompareMedicines side by side. Open data: all countriesEvery price table as a CSV file.
The medicines themselves What it is, how it works, results and side effects (any country).
DulaglutideLiraglutideSemaglutideTirzepatide

Use this table

Download this table (CSV)

38 rows, one per dose. UTF‑8, opens in Excel. Free to reuse under CC BY 4.0: cite GLP Guidebook with the page URL. Open data: all countries

How to cite

GLP Guidebook. GLP-1 medicines and prices in Canada. https://glpguidebook.com/ca/medicines/ (prices checked 12 Oct 2026). Licence: CC BY 4.0.

Questions people ask

How much does Wegovy cost in Canada?

The maker's price submitted to Canada's Drug Agency of Wegovy is $388.64 at every dose, for a pack of 4 weekly doses. That comes to about $5,052 a year.2

How much does Zepbound cost in Canada?

The maker's price submitted to Canada's Drug Agency of Zepbound is $300 at 2.5 and 5 mg, $420 at 7.5 and 10 mg and $540 at 12.5 and 15 mg, for a pack of 4 weekly doses. That comes to about $3,900–$7,020 a year.17

Is that what I pay at the pharmacy?

Not exactly. The pharmacy adds its markup and dispensing fee; the BC wholesale estimates (marked ≈) leave both out.3 What you pay then depends on your plan. Ontario's public plan covers semaglutide for adults with type 2 diabetes under Limited Use rules;18 BC PharmaCare doesn't cover Wegovy;19 and only a small number of private insurers cover these medicines for weight management.20

Which of these medicines are for type 2 diabetes only?

Trulicity, Victoza, Generic semaglutide, Ozempic, Rybelsus and Mounjaro are approved in Canada for type 2 diabetes only, and the table labels them "Type 2 diabetes only".5,8,9,10,11,14 Some contain the same medicine as a brand approved for weight (Ozempic and Wegovy are both semaglutide), but the approved uses, doses and price differ.

Why is a year 13 pens and not 12?

A weekly pen holds 4 doses, so it lasts 4 weeks. A year is 52 weeks, so it takes 13 pens, and a month (a twelfth of the year) costs a little more than one pen. For daily medicines we count 364 days. This is how our cost calculator counts.

Why don't you show the cheapest price or pharmacy prices?

We show official prices from public sources only. Sellers' prices change often and differ from shop to shop, and listing them would turn a guide into a shopping list. That's why the table is grouped by medicine, never sorted by price, and names no pharmacy, clinic or online seller. How we show prices.

Sources

  1. Ontario Ministry of Health. Ontario Drug Benefit Formulary: generic semaglutide (Apotex, Dr. Reddy's) $78.141 per pen; Ozempic $227.94 per pen, interchangeable, with the plan paying the generic price; Sevmia $325.048 per pen, listed off-formulary; Rybelsus $7.5303 per tablet at every strength (1.5, 3, 4, 7, 9 and 14 mg), Limited Use; tirzepatide, liraglutide (Victoza, Saxenda) and dulaglutide (Trulicity) not listed. Checked 12 Oct 2026. Link
  2. Canada's Drug Agency (CDA-AMC). Semaglutide (Wegovy) review SR0841, pharmacoeconomic report: FlexTouch "multiuse prefilled pens that contain 4 doses. The unit cost is $388.64 per pen (or $97.16 per dose)… the cost of pens is the same for all doses" (the maker's submitted price). July 2025. Link
  3. BC Ministry of Health, Provincial Academic Detailing Service. Refills: diabetes drug table update, September 2026. Approximate annual cost "without mark-up or professional fee rounded up to the nearest $5 calculated from McKesson Canada July 27, 2026": Trulicity $3,450 (0.75 mg) to $3,475 (1.5 mg); Victoza $1,430 (0.6 mg) to $4,280 (1.8 mg); Rybelsus, Trulicity and Victoza are PharmaCare non-benefits. Checked 12 Oct 2026. Link
  4. Health Canada. Drug Product Database: GLP-1 product records and schedules (all "Prescription"; Mounjaro for type 2 diabetes; Rybelsus for type 2 diabetes; no oral Wegovy or orforglipron listed). Searched 12 October 2026. health-products.canada.ca
  5. Eli Lilly Canada. Trulicity (dulaglutide injection) product monograph, revised 5 July 2024: 0.75 mg once weekly to start, may be increased to 1.5 mg (then 3 mg and 4.5 mg after at least 4 weeks each); single-use pens in packs of 2 or 4; type 2 diabetes in adults. Link
  6. Novo Nordisk Canada. Saxenda (liraglutide injection) product monograph, 10 September 2025: 0.6, 1.2, 1.8 and 2.4 mg daily for 1 week each, then 3.0 mg; each pen holds 18 mg, packs of 3 or 5 pens; chronic weight management in adults and teens 12 and over. Link
  7. BC Ministry of Health, Provincial Academic Detailing Service. Medications for weight loss marketed in Canada (May 2024): Saxenda "Approx. annual cost: $5500" at the 3 mg maintenance dose, "without mark-up or professional fee calculated from McKesson Canada May 27, 2024"; PharmaCare non-benefit. The newest official Saxenda figure we found (checked 12 October 2026). Link
  8. Novo Nordisk Canada. Victoza (liraglutide injection) product monograph, 21 August 2025: 0.6 mg once daily for at least one week, then 1.2 mg; after at least one week, 1.8 mg; each pen holds 18 mg ("3 pens (total supply 30 days)" at 1.8 mg); type 2 diabetes in adults. Link
  9. Health Canada product monographs for generic semaglutide: Dr. Reddy's (PM 00084444, authorized 28 April 2026, marketed 6 May 2026) and Apotex (PM 00084514, authorized 1 May 2026, marketed 14 May 2026); type 2 diabetes in adults; the 0.25/0.5 mg pen holds 2 mg ("4 doses of 0.25 mg (starting dose) and 2 doses of 0.5 mg, or 4 doses of 0.5 mg"), the 1 mg pen 4 doses. Link
  10. Novo Nordisk Canada. Ozempic (semaglutide injection) product monograph, 13 July 2026: 0.25 mg weekly for 4 weeks, then 0.5 mg; after at least 4 weeks, 1 mg; after at least 4 more weeks, 2 mg; type 2 diabetes in adults. The 0.25/0.5 mg pen holds 2 mg: "4 doses of 0.25 mg (starting dose) and 2 doses of 0.5 mg, or 4 doses of 0.5 mg"; the 1 mg pen holds 4 doses. Link
  11. Novo Nordisk Canada. Rybelsus (semaglutide tablets) product monograph, 13 July 2026: 3 mg once daily for 30 days, then 7 mg; after at least 30 days, 14 mg (or 1.5 mg, 4 mg and 9 mg in the newer tablets); type 2 diabetes in adults; packs of 30, 60 or 90 tablets. Link
  12. Apotex. Sevmia (semaglutide injection) product monograph, date of authorization 29 June 2026: "Multi-use pre-filled pen delivering doses of 1 mg", 4 mg per pen, 1 pen (4 doses) a pack; weight management in adults and teens 12 and over, and non-fatal heart attack risk in adults with heart disease and a BMI of 27 or more; section 4.2: "SEVMIA can be prescribed only for 1 mg once weekly dosing. Alternative products are needed to achieve doses of Semaglutide Injection exclusive of the 1 mg dose" (the label's steps are 0.25, 0.5, 1 and 1.7 mg for 4 weeks each, then 2.4 mg). Link
  13. Novo Nordisk Canada. Wegovy (semaglutide injection) product monograph, revised 2 October 2026: 0.25, 0.5, 1 and 1.7 mg weekly for 4 weeks each, then 2.4 mg (or 1.7 mg); weight management in adults and teens 12 and over, non-fatal heart attack risk, MASH; side effects and warnings. Link
  14. Eli Lilly Canada. Mounjaro (tirzepatide injection) product monograph, 23 June 2026: type 2 diabetes; same dose steps as Zepbound. Link
  15. Canada's Drug Agency (CDA-AMC). Tirzepatide (Mounjaro) reimbursement recommendation SR0886 (meetings 25 March and 22 July 2026): the same submitted prices, $300.00 per 2.5 or 5 mg multidose prefilled pen, $420.00 per 7.5 or 10 mg pen and $540.00 per 12.5 or 15 mg pen; "dulaglutide … is not currently funded by jurisdictions in Canada". Checked 12 Oct 2026. Link
  16. Eli Lilly Canada. Zepbound (tirzepatide injection) product monograph, 11 June 2026: 2.5 mg weekly for 4 weeks, then 5 mg; increase by 2.5 mg after at least 4 weeks on the current dose, to at most 15 mg; "The ZEPBOUND multi-dose KwikPen contains 4 doses". Link
  17. Canada's Drug Agency (CDA-AMC). Tirzepatide (Zepbound) reimbursement recommendation SR0920 (committee meeting 24 June 2026): "At the submitted price of $300.00 per 2.5 mg or 5 mg multidose prefilled pen, $420.00 per 7.5 mg or 10 mg multidose prefilled pen, and $540.00 per 12 mg or 15 mg multidose prefilled pen" (the maker's submitted price; each KwikPen holds 4 weekly doses). Checked 12 Oct 2026. Link
  18. Ontario Ministry of Health. Executive Officer notice, January 2024: semaglutide Limited Use for adults with type 2 diabetes when blood sugar isn't controlled on the maximum tolerated dose of metformin, or metformin can't be used. Also: Get coverage for prescription drugs (who the Ontario Drug Benefit covers). Link
  19. BC PharmaCare. Drug coverage decision: semaglutide (Wegovy), 18 December 2025 ("Non-benefit"; the pan-Canadian Pharmaceutical Alliance ended negotiations without agreement on 1 December 2025; Novo Nordisk no longer seeking public coverage of Wegovy in Canada). Link
  20. Global News. Novo Nordisk to cut Ozempic price as generics arrive ("only a small number of private insurers cover the use of the drugs for weight management"; a savings card excluding Quebec; "Alberta treats Ozempic as a step therapy"), 26 May 2026. Link